| Bioactivity | Endotoxin inhibitor TFA is a synthetic peptide that binds lipid A with high affinity, thereby detoxifying LPS (HY-D1056) and preventing LPS-induced cytokine release in vivo. Endotoxin inhibitor TFA inhibits the febrile response to LPS with very low toxicity and lethality[1]. | ||||||
| Name | Endotoxin inhibitor TFA | ||||||
| Sequence | Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys (Disulfide bridge: Cys4-Cys10) | ||||||
| Shortening | KTKCKFLKKC (Disulfide bridge: Cys4-Cys10) | ||||||
| Formula | C67H103F18N15O24S2 | ||||||
| Molar Mass | 1908.72 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Endotoxin inhibitor TFA
CAS: F: C67H103F18N15O24S2 W: 1908.72
Endotoxin inhibitor TFA is a synthetic peptide that binds lipid A with high affinity, thereby detoxifying LPS (HY-D1056)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.